Trans Dermal Testosterone Compared to Intramuscular Testosterone for Young Males with Delayed Puberty: A PRISMA Guided Systematic Review

References

• Jin H-Y, Lim J-S, Lee Y, et al. Growth, puberty, and bone health in children and adolescents with inflammatory bowel disease. BMC Pediatr. 2021;21(1). doi:10.1186/s12887-021-02496-4
   Web of Science ®Google Scholar
• Wu H-M, Chang H-M, Leung PCK. Gonadotropin-releasing hormone analogs: mechanisms of action and clinical applications in female reproduction. Front Neuroendocrinol. 2021;60:100876. doi:10.1016/j.yfrne.2020.100876
   PubMed Web of Science ®Google Scholar
• Witchel SF, Plant TM. Neurobiology of puberty and its disorders. Human Hypothal Neuroendocr Disord. 2021;463–496. doi:10.1016/b978-0-12-820683-6.00033-6
   Google Scholar
• Matsumoto AM. Diagnosis and Evaluation of Hypogonadism. Endocrinol Metab Clin North Am. 2022;51(1):47–62. doi:10.1016/j.ecl.2021.11.001
   PubMed Web of Science ®Google Scholar
• Persani L, Bonomi M, Cools M, et al. Endo-ERN Expert opinion on the differential diagnosis of pubertal delay. Endocrine. 2021;71(3):681–688. doi:10.1007/s12020-021-02626-z
   PubMed Web of Science ®Google Scholar
• Jayasena CN, Anderson RA, Llahana S, et al. Society for endocrinology guidelines for testosterone replacement therapy in male hypogonadism. Clin Endocrinol. 2021;96(2):200–219. doi:10.1111/cen.14633
   PubMed Web of Science ®Google Scholar
• Federici S, Goggi G, Quinton R, et al. New and consolidated therapeutic options for pubertal induction in hypogonadism: in-depth review of the literature. Endocr Rev. 2021;43(5):824–851. doi:10.1210/endrev/bnab043
   Web of Science ®Google Scholar
• Grinspon RP, Castro S, Brunello FG, et al. Diagnosis of Male central hypogonadism during childhood. J Endocr Soc. 2021;5(11). doi:10.1210/jendso/bvab145
   PubMed Web of Science ®Google Scholar
• Harrington J, Palmert MR. An approach to the patient with delayed puberty. J Clin Endocrinol Metab. 2022;107(6):1739–1750. doi:10.1210/clinem/dgac054
   PubMed Web of Science ®Google Scholar
• Ehrensaft D, Tishelman AC. Take the T out, Put the T in: gender‐affirming hormones in youth. Andrology. 2021;9(6):1698–1706. doi:10.1111/andr.13055
   PubMed Web of Science ®Google Scholar
• Grannis C, Leibowitz SF, Gahn S, et al. Testosterone treatment, internalizing symptoms, and body image dissatisfaction in transgender boys. Psychoneuroendocrinology. 2021;132:105358. doi:10.1016/j.psyneuen.2021.105358
   PubMed Web of Science ®Google Scholar
• Desai A, Yassin M, Cayetano A, et al. Understanding and managing the suppression of spermatogenesis caused by Testosterone Replacement Therapy (TRT) and Anabolic–Androgenic Steroids (AAS). Ther Adv Urol. 2022;14:175628722211050. doi:10.1177/17562872221105017
   Web of Science ®Google Scholar
• Corona G, Vena W, Pizzocaro A, et al. Testosterone supplementation and bone parameters: a systematic review and meta-analysis study. J Endocrinol Invest. 2022;45(5):911–926. doi:10.1007/s40618-021-01702-5
   PubMed Web of Science ®Google Scholar
• Lanier NE, Nguyen CM, Mihalopoulos NL, et al. 54. Adolescent transgender boys: effects of 2 years of testosterone therapy. J Adolesc Health. 2022;70(4):S29. doi:10.1016/j.jadohealth.2022.01.167
   Web of Science ®Google Scholar
• Al Samahy O, Othman D, Gad D, et al. Efficacy of topical testosterone in management of scrotal hypoplasia and agenesis. J Pediatr Urol. 2021;17(4):515.e1–515.e8. doi:10.1016/j.jpurol.2021.02.014
   PubMed Web of Science ®Google Scholar
• Cohen J, Nassau DE, Patel P, et al. Low testosterone in adolescents & young adults. Front Endocrinol. 2020;10. doi:10.3389/fendo.2019.00916
   PubMed Web of Science ®Google Scholar
• Kresch E, Patel M, Lima TF, Ramasamy R. An update on the available and emerging pharmacotherapy for adults with testosterone deficiency available in the USA. Expert Opin Pharmacother. 2021;22(13):1761–1771. doi:10.1080/14656566.2021.1918101
   PubMed Web of Science ®Google Scholar
• Patel M, Muthigi A, Ramasamy R. JATENZO®: challenges in the development of oral testosterone. Int J Impot Res. 2021;34(7):721–724. doi:10.1038/s41443-021-00461-4
   PubMed Web of Science ®Google Scholar
• Figueiredo MG, Gagliano-Jucá T, Basaria S. Testosterone therapy with subcutaneous injections: a safe, practical, and reasonable option. J Clin Endocrinol Metab. 2021;107(3):614–626. doi:10.1210/clinem/dgab772
   Web of Science ®Google Scholar
• Suarez AMC, Israeli JM, Kresch E, et al. Testosterone therapy in children and adolescents: to whom, how, when? Int J Impot Res. 2022;34(7):652–662. doi:10.1038/s41443-021-00525-5
   PubMed Web of Science ®Google Scholar
• Zacharin MR, Warne GL. Treatment of hypogonadal adolescent boys with long acting subcutaneous testosterone pellets. Arch Dis Child. 1997;76(6):495–499. doi:10.1136/adc.76.6.495
   PubMed Web of Science ®Google Scholar
• Vogiatzi M, Tursi JP, Jaffe JS, et al. Testosterone use in adolescent males: current practice and unmet needs. J Endocr Soc. 2020;5(1). doi:10.1210/jendso/bvaa161
   PubMed Web of Science ®Google Scholar
• Pastuszak AW, Gittelman M, Tursi JP, et al. Pharmacokinetics of testosterone therapies in relation to diurnal variation of serum testosterone levels as men age. Andrology. 2021;10(2):209–222. doi:10.1111/andr.13108
   PubMed Web of Science ®Google Scholar
• Abildgaard J, Petersen JH, Bang AK, et al. Long‐term testosterone undecanoate treatment in the elderly testosterone deficient male: an observational cohort study. Andrology. 2021;10(2):322–332. doi:10.1111/andr.13124
   PubMed Web of Science ®Google Scholar
• Shankara Narayana N, Ly LP, Jayadev V, et al. Optimal injection interval for testosterone undecanoate treatment of hypogonadal and transgender men. Endocr Connect. 2021;10(7):758–766. doi:10.1530/EC-21-0109
   PubMed Web of Science ®Google Scholar
• White WB, Dobs A, Carson C, et al. Effects of a novel oral testosterone undecanoate on ambulatory blood pressure in Hypogonadal Men. J Cardiovasc Pharmacol Ther. 2021;26(6):630–637. doi:10.1177/10742484211027394
   PubMed Web of Science ®Google Scholar
• Ahmad SW, Molfetto G, Montoya D, et al. Is oral testosterone the new frontier of testosterone replacement therapy? Cureus. 2022;14(8). doi:10.7759/cureus.27796
   Web of Science ®Google Scholar
• Khodamoradi K, Khosravizadeh Z, Parmar M, et al. Exogenous testosterone replacement therapy versus raising endogenous testosterone levels: current and future prospects. F&S Rev. 2021;2(1):32–42. doi:10.1016/j.xfnr.2020.11.001
   PubMedGoogle Scholar
• Hashim PH, Kinnear HM, Cruz CD, et al. Pharmacokinetic comparison of three delivery systems for subcutaneous testosterone administration in female mice. Gen Comp Endocrinol. 2022;327:114090. doi:10.1016/j.ygcen.2022.114090
   PubMed Web of Science ®Google Scholar
• Barbonetti A, D’Andrea S, Francavilla S. Testosterone replacement therapy. Andrology. 2020;8(6):1551–1566. doi:10.1111/andr.12774
   PubMed Web of Science ®Google Scholar
• Ghosh T, Abraham W, Jasti B. Transdermal and topical drug delivery systems. In: Theory and Practice of Contemporary Pharmaceutics. CRC Press; 2004:423–455.
   Google Scholar
• Zeng J, Xie T-F, Huang T, et al. Preparation and in vitro and in vivo evaluation of a testosterone film forming gel for the treatment of hypoactive sexual desire disorder in women. AAPS Pharm Sci Tech. 2022;23(3). doi:10.1208/s12249-021-02201-9
   Web of Science ®Google Scholar
• Dubey R, Pothuvan U. Transdermal patches: an emerging mode of drug delivery system in Pulmonary arterial hypertension. J Drug Deliv Ther. 2021;11(4–S):176–186. doi:10.22270/jddt.v11i4-S.4925
   Google Scholar
• Farooqui H, Upadhyay P, Upadhyay S. Transdermal patches approach towards self-nano-emulsifying drug delivery system (SNEDDS) using essential oil as penetration enhancer. Micro Nanosyst. 2022;14(4):314–340. doi:10.2174/1876402914666220221105304
   Google Scholar
• Al Hanbali OA, Khan HM, Sarfraz M, Arafat M, Ijaz S, Hameed A. Transdermal patches: design and current approaches to Painless Drug Delivery. Acta Pharmaceutica. 2019;69(2):197–215. doi:10.2478/acph-2019-0016
   PubMed Web of Science ®Google Scholar
• Mani SB, Clavijo RI. Medical treatment of hypogonadism in men. Urol Clin North Am. 2022;49(2):197–207. doi:10.1016/j.ucl.2021.12.008
   PubMed Web of Science ®Google Scholar
• Smurawa TM, Congeni JA. Testosterone precursors: use and abuse in pediatric athletes. Pediatr Clin North Am. 2007;54(4):787–796. doi:10.1016/j.pcl.2007.05.002
   PubMed Web of Science ®Google Scholar
• Malik RD, Liu DB. Survey of pediatric urologists on the preoperative use of testosterone in the surgical correction of hypospadias. J Pediatr Urol. 2014;10(5):840–843. doi:10.1016/j.jpurol.2014.02.008
   PubMed Web of Science ®Google Scholar
• Funderburgh LJ, Zipf W, Sotos JF. [PDF] direct measurement of testosterone in a pediatric center, with use of a radioimmunoassay kit and unextracted serum.: semantic scholar. Clin Chem. 1983;29(10):1796–1798. doi:10.1093/clinchem/29.10.1796
   PubMed Web of Science ®Google Scholar
• Arisaka O, Hoshi M, Kanazawa S, et al. Systemic effects of transdermal testosterone for the treatment of microphallus in children. Pediatr Int. 2001;43(2):134–136. doi:10.1046/j.1442-200x.2001.01353.x
   PubMed Web of Science ®Google Scholar
• Rey RA, Grinspon RP. Androgen treatment in adolescent males with hypogonadism. Am Jo Men’s Health. 2020;14(3):155798832092244. doi:10.1177/1557988320922443
   Web of Science ®Google Scholar
• Takeuchi H, Okubo H. Clinical efficiency of combination therapy using testosterone replacement therapy, phosphodiesterase 5 inhibitors and Kampo herbal medicine for EUGONADAL patients with late-onset hypogonadism syndrome. Exp Ther Med. 2021;22(4). doi:10.3892/etm.2021.10608
   PubMed Web of Science ®Google Scholar
• Lee J, Brock G, Barkin J, et al. The my-T study: patient satisfaction and preference comparing topical and nasal testosterone therapies. Can Urol Assoc J. 2019;13(11). doi:10.5489/cuaj.5680
   Google Scholar
• Schiavo JH. Prospero: an international register of systematic review protocols. Med Ref Serv Q. 2019;38(2):171–180. doi:10.1080/02763869.2019.1588072
   PubMedGoogle Scholar
• Liberati A, Altman D, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of clinical epidemiology. 2009;62(10). doi:10.1136/bmj.b2700
   Google Scholar
• Hong QN, Pluye P, Fàbregues S, et al. Improving the content validity of the mixed methods appraisal tool: a modified e-delphi study. J Clin Epidemiol. 2019;109:111. doi:10.1016/j.jclinepi.2019.01.012
   PubMedGoogle Scholar
• Harrison R, Jones B, Gardner P, Lawton R. Quality Assessment with diverse studies (Quads): an appraisal tool for methodological and reporting quality in systematic reviews of mixed- or multi-method studies. BMC Health Serv Res. 2021;21(1):1–20.
   PubMed Web of Science ®Google Scholar
• Lizarondo L, Stern C, Apostolo J, et al. Five common pitfalls in mixed methods systematic reviews: lessons learned. J Clin Epidemiol. 2022;148:178–183. doi:10.1016/j.jclinepi.2022.03.014
   PubMed Web of Science ®Google Scholar
• Stancampiano MR, Lucas-Herald AK, Russo G, et al. Testosterone therapy in adolescent boys: the need for a structured approach. Horm Res Paediatr. 2019;92(4):215–228. doi:10.1159/000504670
   PubMed Web of Science ®Google Scholar
• Mastromattei S, Todisco T, Chioma L, et al. Efficacy of short-term induction therapy with low-dose testosterone as a diagnostic tool in the workup of delayed growth and puberty in boys. J Endocrinol Invest. 2022;45(12):2377–2384. doi:10.1007/s40618-022-01879-3
   PubMed Web of Science ®Google Scholar
• Chioma L, Papucci G, Fintini D, et al. Use of testosterone gel compared to intramuscular formulation for puberty induction in males with constitutional delay of growth and puberty: a preliminary study. J Endocrinol Invest. 2017;41(2):259–263. doi:10.1007/s40618-017-0726-7
   PubMed Web of Science ®Google Scholar
• Lucas-Herald AK, Mason E, Beaumont P, et al. Single-centre experience of testosterone therapy for boys with hypogonadism. Horm Res Paediatr. 2018;90(2):123–127. doi:10.1159/000490738
   PubMed Web of Science ®Google Scholar
• Contreras MF, Raisingani M, Prasad K, Franklin B, Shah B. Transdermal testosterone gel for induction and continuation of puberty in adolescent boys with hepatic dysfunction. J Pediatr Endocrinol Metabol. 2017;30(1). doi:10.1515/jpem-2016-0201
   PubMed Web of Science ®Google Scholar
• Johansen N, Lindén Hirschberg A, Moen MH. The role of testosterone in menopausal hormone treatment. What is the evidence? Acta Obstet Gynecol Scand. 2020;99(8):966–969. doi:10.1111/aogs.13819
   PubMed Web of Science ®Google Scholar
• Lin L-T, Li C-J, Tsui K-H. Serum testosterone levels are positively associated with serum anti-mullerian hormone levels in infertile women. Sci Rep. 2021;11(1):6336.
   PubMed Web of Science ®Google Scholar
• Diem SJ, Greer NL, MacDonald R, et al. Efficacy and safety of testosterone treatment in men: an evidence report for a clinical practice guideline by the American College of Physicians. Ann Intern Med. 2020;172(2):105. doi:10.7326/M19-0830
   PubMed Web of Science ®Google Scholar
• Nolan BJ, Proietto J, Sumithran P. Single‐Center Real‐life experience with testosterone treatment in adult men with Prader–Willi syndrome. Am J Med Genet A. 2022;188(9):2637–2641. doi:10.1002/ajmg.a.62770
   PubMed Web of Science ®Google Scholar
• Madsen MC, van Dijk D, Wiepjes C, et al. M. Erythrocytosis in a large cohort of trans men using testosterone: a long term follow up study on prevalence, determinants, and the effect of years of exposure. J Endocr Soc. 2021;5(Supplement_1):A726–A726. doi:10.1210/jendso/bvab048.1477
   Google Scholar
• Bhasin S, Lincoff AM, Basaria S, et al. Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: rationale and design of the Traverse Study. Am Heart J. 2022;245:41–50. doi:10.1016/j.ahj.2021.11.016
   PubMed Web of Science ®Google Scholar
• Salamin O, Nicoli R, Langer T, et al. Longitudinal evaluation of multiple biomarkers for the detection of testosterone gel administration in women with normal menstrual cycle. Drug Test Anal. 2021;14(5):833–850. doi:10.1002/dta.3040
   PubMed Web of Science ®Google Scholar
• Donaldson M, Kriström B, Ankarberg-Lindgren C, et al. Optimal pubertal induction in girls with Turner syndrome using either oral or transdermal estradiol: a proposed modern strategy. Horm Res Paediatr. 2019;91(3):153–163. doi:10.1159/000500050
   PubMed Web of Science ®Google Scholar